Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R44DK120242-03
A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury
Recipient
Not specified
Award Amount
$1,019,958.00
Ceiling
$1,019,958.00
Awarded
February 29, 2024
Identifier
5R44DK120242-03
Development of a silicon nanopore membrane blood filter for anticoagulant-free continuous renal replacement therapy, funded by NIH NIDDK under SBIR Phase II, with a total award amount of approximately $1.02 million.
Description
The project involves developing a blood filter based on silicon nanopore membrane technology for use in renal replacement therapy. The project aims to operate without anticoagulants, reducing costs and complications. The award is part of SBIR Phase II, focusing on clinical-scale development and testing. The project emphasizes innovation in biomaterials and medical device technology.